TRIM59 is highly expressed in NAFLD tissues, where it interacts with GPX4 and promotes its ubiquitination, thereby accelerating fatty degeneration and ferroptosis in NAFLD [198]. Here, GPX4 is linked to metabolic dysfunction-associated steatotic liver disease.